Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegaserod in chronic constipation
NCT00149877Phase 4Completed
- Sponsor
- Novartis
- Start
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tegaserod in chronic constipation, sponsored by Novartis. Primary endpoint: Number of complete spontaneous bowel movements during the first 4 weeks of treatment. Started Apr 2004; status: completed.
02
Drugs
tegaserod
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT00149877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00149877.